PTAB Nixes Patent Claims UPenn Said Erbitux Infringed
The Patent Trial and Appeal Board invalidated claims in a University of Pennsylvania patent on a tumor treatment Thursday, handing a win to Eli Lilly Co., which faced allegations that its...To view the full article, register now.
Already a subscriber? Click here to view full article